Please assess the completion status of the following clinical trial:

Trial Title: Sentinel Node Detection in Ovarian Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a high suspicion of a malignant ovarian tumour planned for exploratory laparotomy. Only when a malignancy is confirmed by frozen section, the SNs will be removed prior to proceeding with a complete staging procedure.~* Patients in whom the ovarian malignant tumour has already been resected and a second surgical procedure is planned to complete the staging procedure including lymph nodes.~* Mentally competent to give informed consent.~Exclusion Criteria:~* Previous vascular surgery of the aorta, caval vein, and/or iliac vessels.~* Previous lymphadenectomy of lymph node sampling in the iliac or para-aortal region.~* History of a malignant lymphoma.~* History of a malignant tumour in the abdominal cavity.~* Previous allergic reaction to blue dye.~* Pregnant or lactating patients.~* An allergy for human albumin.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Sentinel node procedure. (Type: EXPERIMENTAL): Intervention: injection of blue dye and radioactive tracer (99mTc-nanocolloid or Nanocoll) in remains of the ovarian ligaments.

Based on this trial design, predict the completion outcome and termination type (if applicable).